Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion type Assertion NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_head.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion evidence source_evidence_literature NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion SIO_000772 15000491 NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion wasDerivedFrom befree-20150227 NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.
- NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion wasGeneratedBy ECO_0000203 NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.